Clinical features and outcomes of coronavirus disease 2019 in early infants in Japan: A case series and literature review.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 18 10 2021
revised: 20 12 2021
accepted: 22 12 2021
pubmed: 15 1 2022
medline: 17 3 2022
entrez: 14 1 2022
Statut: ppublish

Résumé

The clinical picture in early infants with COVID-19 has been described in a limited number of reports, mainly from European countries, United States, and China, but not Japan. Although several reports suggested that early infants can develop more severe COVID-19 disease than older children, risk factors for severe illness and differences according to nationality or ethnicity remain unclear. We report a case series of 13 infants ≤90 days old with COVID-19 in Japan. All patients had mild outcomes and did not require respiratory support or intensive care.

Identifiants

pubmed: 35027300
pii: S1341-321X(21)00362-7
doi: 10.1016/j.jiac.2021.12.026
pmc: PMC8733281
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

582-586

Informations de copyright

Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Références

Front Pediatr. 2021 Jul 12;9:674899
pubmed: 34322461
Clin Pediatr (Phila). 2021 May;60(4-5):247-251
pubmed: 33853371
J Pediatr. 2021 Jan;228:94-100.e3
pubmed: 32910943
Acta Paediatr. 2020 Oct;109(10):1948-1955
pubmed: 32557789
J Pediatr. 2020 Sep;224:150-152
pubmed: 32565095
J Trop Pediatr. 2021 Jul 2;67(3):
pubmed: 32856065
Arch Dis Child Fetal Neonatal Ed. 2021 May;106(3):330-335
pubmed: 32943533
Pediatrics. 2020 Sep;146(3):
pubmed: 32527752
JAMA Netw Open. 2020 Dec 1;3(12):e2030470
pubmed: 33315110
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Eur J Pediatr. 2021 Jul;180(7):2099-2106
pubmed: 33606120

Auteurs

Hiroyuki Iijima (H)

Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan. Electronic address: iijima-hi@ncchd.go.jp.

Takanori Funaki (T)

Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.

Mitsuru Kubota (M)

Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH